4556.T
The company operates in the healthcare services and equipment sector, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment sector, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment sector, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company maintains a strong liquidity position, with a current ratio of 4.0, indicating a robust ability to meet short-term obligations. Its cash and equivalents amount to ¥3,396,322,000, which is significantly higher than its total liabilities of ¥2,009,966,000, further reinforcing its liquidity strength. The price-to-book ratio of 1.41 and the price-to-tangible-book ratio of 1.41 suggest that the company is trading at a moderate premium to its book value.
In terms of profitability, the company's return on equity (ROE) of 9.46% and return on assets (ROA) of 7.3% are strong indicators of efficient capital utilization and asset management. The operating margin, calculated as operating income of ¥822,380,000 divided by revenue of ¥5,305,569,000, is approximately 15.5%, which is a solid margin for the industry. The company's debt-to-equity ratio of 0.09 indicates a conservative capital structure with minimal leverage.
The company's revenue is concentrated in the healthcare services and equipment sector, with no disclosed geographic diversification in the provided data. This concentration may expose the company to sector-specific risks, such as regulatory changes or shifts in healthcare demand.
The company's growth trajectory is supported by a strong operating cash flow of ¥704,781,000 and a free cash flow of ¥525,018,000, which provide flexibility for reinvestment or shareholder returns. The capital expenditure of -¥76,936,000 suggests that the company is not currently investing heavily in new assets, which may indicate a focus on maintaining existing operations.
The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high cash reserves further support the low liquidity risk profile. There is no indication of dilution potential in the basic shares outstanding, as the number of basic and diluted shares is the same.
Recent events, as reflected in the financial data, show a stable financial position with consistent revenue and profit generation. The company's financial health appears to be supported by its strong cash position and conservative leverage, which may provide resilience against market volatility.
- The company has a strong liquidity position, supported by a high current ratio and substantial cash reserves.
- The company's profitability metrics, including ROE and ROA, are strong and indicate efficient capital and asset utilization.
- The company's revenue is concentrated in the healthcare services and equipment sector, which may expose it to sector-specific risks.
- The company's conservative capital structure, with a low debt-to-equity ratio, reduces financial risk.
- The company's strong operating and free cash flows provide flexibility for growth and shareholder returns.
- The company's low liquidity and dilution risks, as per the risk assessment, suggest a stable financial outlook.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 4556.T Market data — financials · 2026-05-26